Shufang HAN, Yuqi GAO, Jie FANG, et al. Type 1 T helper /type 2 T helper imbalance accelerates vascular endothelial injury in coronary heart disease patients with hyperglycemia[J]. Journal of Army Medical University, 2022, 44(6): 576-581.
DOI:
Shufang HAN, Yuqi GAO, Jie FANG, et al. Type 1 T helper /type 2 T helper imbalance accelerates vascular endothelial injury in coronary heart disease patients with hyperglycemia[J]. Journal of Army Medical University, 2022, 44(6): 576-581. DOI: 10.16016/j.2097-0927.202201034.
Type 1 T helper /type 2 T helper imbalance accelerates vascular endothelial injury in coronary heart disease patients with hyperglycemia
To observe the changes of type 1 T helper cells (Th1)/type 2 T helper cells (Th2) in peripheral blood of the patients with coronary heart disease (CHD) under different blood glucose conditions
and to investigate the involvement of the changes of Th1/Th2 subsets under different blood glucose conditions on vascular endothelial injury.
Methods
2
Seventy-three CHD patients diagnosed in our hospital from January 2019 to April 2021 and 20 healthy volunteers (control group) were enrolled in this study. According to the blood glucose level of the CHD patients
they were divided into diabetes group (group DM
n
=25)
impaired glucose tolerance group (group IGR
n
=10) and normal blood glucose group (group N
n
=38). The percentages of Th1/Th2 cell subsets and the concentration of Th1/Th2 related cytokines in the peripheral blood were measured. Cytotoxic activity of different cell subsets against human umbilical vein endothelial cells (HUVECs) were evaluated.
Results
2
The percentage of Th1 cells and concentration of interferonγ (IFNγ) were significantly higher in the group DM than the groups IGR
N and Control [percentage of Th1 cells; (10.13±2.34) %
vs
(6.38±0.89)%
(
6.13±1.19)% and (6.26±1.18)%
P
<
0.05; IFNγ: 58.29±8.24
vs
47.60±3.91
47.69±5.08 and 39.18±4.34 pg/mL
P
<
0.05
]
. While the concentration of interleukin-10 (IL-10) in the group DM was obviously lower than that in the other 3 groups (20.74±3.61
vs
23.83±4.23
30.03±4.28 and 35.69±4.25 pg/mL
P
<
0.05). Cytotoxic efficiency of peripheral blood mononuclear cells (PBMC) to HUVEC was significantly elevated in the group DM than the other 3 groups [(67.69±1.96)%
vs
(78.19±4.02)%
(77.78±2.78)% and (77.64±4.01)%
P
<
0.05
]
. But there was no statistical difference in the elimination of CD4
+
T cells in the group DM and the other 3 groups.
Conclusion
2
CHD patients with hyperglycemia present obvious imbalances of Th1/Th2 cells and cytokines in the peripheral blood
which promoting the damage of hyperglycemia to vascular endothelial cells.
关键词
Keywords
references
MA R C W. Epidemiology of diabetes and diabetic complications in China[J]. Diabetologia, 2018, 61(6): 1249-1260. DOI: 10.1007/s00125-018-4557-7.
POZNYAK A, GRECHKO A V, POGGIO P, et al . The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation[J ] . Int J Mol Sci, 2020, 21(5): E1835. DOI: 10.3390/ijms21051835.
GILICZE O, SIMON D, FARKAS N, et al . Characterization of lymphocyte subpopulations and cardiovascular markers in pericardial fluid of cardiac surgery patients[J ] . Clin Hemorheol Microcirc, 2019, 73(4): 579-590. DOI: 10.3233/CH-190594.
VⅡGIMAA M, SACHINIDIS A, TOUMPOURLEKA M, et al . Macrovascular complications of type 2 diabetes mellitus[J ] . Curr Vasc Pharmacol, 2020, 18(2): 110-116. DOI: 10.21 74/1570161117666190405165151.
YUAN T, YANG T, CHEN H, et al . New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis[J ] . Redox Biol, 2019, 20: 247-260. DOI: 10.1016/j.redox.2018.09.025.
SHAO F, ZHENG P L, YU D, et al . Follicular helper T cells in type 1 diabetes[J ] . FASEB J, 2020, 34(1): 30-40. DOI: 10.1096/fj.201901637R.
SAIGUSA R, WINKELS H, LEY K. T cell subsets and functions in atherosclerosis[J]. Nat Rev Cardiol, 2020, 17(7): 387-401. DOI: 10.1038/s41569-020-0352-5.
GISTERÅ A, HANSSON G K. The immunology of atherosclerosis[J]. Nat Rev Nephrol, 2017, 13(6): 368-380. DOI: 10.1038/nrneph.2017.51.
ALI A J, MAKINGS J, LEY K. Regulatory T cell stability and plasticity in atherosclerosis[J]. Cells, 2020, 9(12): 2665. DOI: 10.3390/cells9122665.
ALBANY C J, TREVELIN S C, GIGANTI G, et al . Getting to the heart of the matter: the role of regulatory T- cells (tregs) in cardiovascular disease (CVD) and atherosclerosis[J ] . Front Immunol, 2019, 10: 2795. DOI: 10.3389/fimmu.2019.02795.
HAN S F, LIU P, ZHANG W, et al . The opposite-direction modulation of CD4 + CD25+ Tregs and T helper 1 cells in acute coronary syndromes[J ] . Clin Immunol, 2007, 124(1): 90-97. DOI: 10.1016/j.clim.2007.03.546..
OLSON N C, DOYLE M F, DE BOER I H, et al . Associations of circulating lymphocyte subpopulations with type 2 diabetes: cross-sectional results from the multi-ethnic study of atherosclerosis (MESA)[J ] . PLoS One, 2015, 10(10): e0139962. DOI: 10.1371/journal.pone.0139962.
ZHAO S L, MO Z H, HE H H, et al . Imbalance of T-helper 1/T-helper 2 cytokines and impaired glucose tolerance among patient with acute coronary syndrome[J ] . J Cancer Res Ther, 2018, 14(Supplement): S480-S485. DOI: 10.4103/0973-1482.194346.
ŠIKLOVÁ M, KRAUZOVÁ E, SVOBODOVÁ B, et al . Circulating monocyte and lymphocyte populations in healthy first-degree relatives of type 2 diabetic patients at fasting and during short-term hyperinsulinemia[J ] . Mediators Inflamm, 2019, 2019: 1491083. DOI: 10.1155/2019/1491083.
GIMBRONE M A Jr, GARCÍA-CARDEÑA G. Endothelial cell dysfunction and the pathobiology of atherosclerosis[J]. Circ Res, 2016, 118(4): 620-636. DOI: 10.1161/CIRCRESAHA.115.306301.
CHRYSOHOOU C, KOLLIA N, TOUSOULIS D. The link between depression and atherosclerosis through the pathways of inflammation and endothelium dysfunction[J]. Maturitas, 2018, 109: 1-5. DOI: 10.1016/j.maturitas.2017.12.001.